About this trial
The study aims to investigate whether tailoring limb lengths based on the 1/3rd and 2/3rd concept improves clinical outcomes in Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) surgery compared to conventional limb lengths. In this study, two groups were described, first group involves patients who will undergo Lap RYGB with conventional limb lengths of 75cms and 125cms, while the second group is given tailored limb lengths according to the total small bowel length. In the follow up period, Total percentage weight loss, improvement in BMI along with the remission of co-morbidities were also assessed.
Eligibility criteria
Qualifiers
Age: 18-65 years
ASA - less than or equal to 3
Informed Consent: Ability and willingness to provide written informed consent and comply with procedures.
Previous Weight Loss Attempts: Documentation of previous attempts at weight loss through diet, exercise, or medical management.
Disqualifiers
Previous Bariatric Surgery: Prior bariatric or major gastrointestinal surgery that might affect the outcome of RYGB.
Severe Cardiopulmonary Conditions: Significant cardiac or pulmonary conditions that pose a high surgical risk (e.g., severe congestive heart failure, severe chronic obstructive pulmonary disease).
Uncontrolled Psychiatric Disorders: Severe psychiatric illness or substance abuse issues that are not well-controlled, including eating disorders.
Pregnancy: Current pregnancy or plans to become pregnant within 12 months post-surgery.
Trial design
Treatments tested in this trial
- Laparoscopic Roux-en Y Gastric bypass (RYGB)- Conventional approach
- Laparoscopic Roux-en Y Gastric bypass (RYGB)- Tailored approach